Literature DB >> 35124722

Reappraisal and literature review of primary cutaneous cribriform apocrine carcinoma.

Anna Davis1, Amor Khachemoune2,3.   

Abstract

Primary cutaneous cribriform apocrine carcinoma (PCCAC) is an exceedingly rare sweat gland carcinoma. Clinically, it most often presents as a singular, asymptomatic nodule or cyst on the extremities of middle-aged patients and follows an indolent course. Both visceral and cutaneous cribriform tumors exist in nature. While a cribriform pattern is well recognized in tumors of visceral organs, there is a paucity in the literature on the defining characteristics for primary cutaneous tumors. Consensus regarding diagnostic criteria, etiology, and management protocols has yet to be achieved. We conducted an extensive literature review using pre-determined search criteria, resulting in 12 identified case reports and series on PCCAC that were subsequently analyzed. All data were compiled to provide a comprehensive update on the existing information regarding clinical presentation, histopathology, and management of reported PCCACs, as well as differential diagnosis, controversial issues, and recommendations for future considerations.
© 2022. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Entities:  

Keywords:  Cribriform carcinoma; Mohs micrographic surgery; Primary cutaneous cribriform apocrine carcinoma; Sweat gland carcinoma

Year:  2022        PMID: 35124722     DOI: 10.1007/s00403-022-02323-5

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  28 in total

1.  Primary cutaneous cribriform carcinoma: a rare apocrine tumour.

Authors:  Henri Adamski; Jacky Le Lan; Stéphane Chevrier; Bernard Cribier; Eric Watier; Jacqueline Chevrant-Breton
Journal:  J Cutan Pathol       Date:  2005-09       Impact factor: 1.587

2.  Primary cutaneous cribriform carcinoma: report of six cases with clinicopathologic data and immunohistochemical profile.

Authors:  David P Arps; May P Chan; Rajiv M Patel; Aleodor A Andea
Journal:  J Cutan Pathol       Date:  2015-03-26       Impact factor: 1.587

Review 3.  Cutaneous Sweat Gland Carcinomas with Basaloid Differentiation: An Update with Emphasis on Differential Diagnoses.

Authors:  Katharina Flux; Thomas Brenn
Journal:  Clin Lab Med       Date:  2017-06-09       Impact factor: 1.935

4.  Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005.

Authors:  Lasse R Braathen; Rolf-Markus Szeimies; Nicole Basset-Seguin; Robert Bissonnette; Peter Foley; David Pariser; Rik Roelandts; Ann-Marie Wennberg; Colin A Morton
Journal:  J Am Acad Dermatol       Date:  2007-01       Impact factor: 11.527

5.  Primary Cutaneous Cribriform Carcinoma Treated With Mohs Micrographic Surgery.

Authors:  Ryan Bogner; Timothy Brown; Paul Fearneyhough; George Gataky
Journal:  Dermatol Surg       Date:  2018-04       Impact factor: 3.398

Review 6.  Apocrine gland carcinoma of the axilla: review of the literature and recommendations for treatment.

Authors:  R S Chamberlain; K Huber; J C White; R Travaglino-Parda
Journal:  Am J Clin Oncol       Date:  1999-04       Impact factor: 2.339

Review 7.  Malignant sweat gland tumours: an update.

Authors:  José C Cardoso; Eduardo Calonje
Journal:  Histopathology       Date:  2015-07-21       Impact factor: 5.087

8.  Skin adnexal neoplasm closely resembling adenomatoid tumor: a unique occurrence.

Authors:  S Crippa; C Di Bella; A Faravelli
Journal:  Int J Surg Pathol       Date:  2006-04       Impact factor: 1.271

9.  Immunohistochemical phenotype of cutaneous cribriform carcinoma with a panel of 15 antibodies.

Authors:  Angel Fernandez-Flores; Antonio Pol; Fernando Juanes; Luis G Crespo
Journal:  Med Mol Morphol       Date:  2007-12-21       Impact factor: 2.309

10.  Surgical management and lymph-node biopsy of rare malignant cutaneous adnexal carcinomas: a population-based analysis of 7591 patients.

Authors:  Amrita Goyal; Theodore Marghitu; Nikhil Goyal; Nathan Rubin; Krishnan Patel; Kavita Goyal; Daniel O'Leary; Kimberly Bohjanen; Ian Maher
Journal:  Arch Dermatol Res       Date:  2020-09-23       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.